These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17400592)

  • 21. Speech intelligibility of Parkinson's disease patients evaluated by different groups of healthcare professionals and naïve listeners.
    Carvalho J; Cardoso R; Guimarães I; Ferreira JJ
    Logoped Phoniatr Vocol; 2021 Oct; 46(3):141-147. PubMed ID: 32633172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between acoustic measures and speech naturalness ratings in Parkinson's disease: A within-speaker approach.
    Klopfenstein M
    Clin Linguist Phon; 2015; 29(12):938-54. PubMed ID: 26403503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there an order of loss of sounds in speakers with Parkinson's disease?
    Read J; Miller N; Kitsou N
    Clin Linguist Phon; 2018; 32(11):997-1011. PubMed ID: 30277104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Listener impressions of speakers with Parkinson's disease.
    Jaywant A; Pell MD
    J Int Neuropsychol Soc; 2010 Jan; 16(1):49-57. PubMed ID: 19758475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clear Speech Variants: An Investigation of Intelligibility and Speaker Effort in Speakers With Parkinson's Disease.
    Stipancic KL; van Brenk F; Kain A; Wilding G; Tjaden K
    Am J Speech Lang Pathol; 2022 Nov; 31(6):2789-2805. PubMed ID: 36327495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of listening conditions and listener characteristics on intelligibility of dysarthric speech.
    Pennington L; Miller N
    Clin Linguist Phon; 2007 May; 21(5):393-403. PubMed ID: 17468997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vowel articulation in Parkinson's disease.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Jul; 25(4):467-72. PubMed ID: 20434876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
    Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
    Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship Between Voice and Motor Disabilities of Parkinson's Disease.
    Majdinasab F; Karkheiran S; Soltani M; Moradi N; Shahidi G
    J Voice; 2016 Nov; 30(6):768.e17-768.e22. PubMed ID: 26725551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2010; 45(6):630-44. PubMed ID: 20102257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease.
    Klostermann F; Ehlen F; Vesper J; Nubel K; Gross M; Marzinzik F; Curio G; Sappok T
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):522-9. PubMed ID: 17766427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An exploration of listener variability in intelligibility judgments.
    McHenry M
    Am J Speech Lang Pathol; 2011 May; 20(2):119-23. PubMed ID: 21317298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acoustic and perceptual speech characteristics of native Mandarin speakers with Parkinson's disease.
    Hsu SC; Jiao Y; McAuliffe MJ; Berisha V; Wu RM; Levy ES
    J Acoust Soc Am; 2017 Mar; 141(3):EL293. PubMed ID: 28372040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
    Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nonspeech investigation of tongue function in Parkinson's disease.
    McAuliffe MJ; Ward EC; Murdoch BE; Farrell AM
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):667-74. PubMed ID: 15972622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Intelligibility Gains in Individuals With Dysarthria From Baseline Speech Features.
    Fletcher AR; McAuliffe MJ; Lansford KL; Sinex DG; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3043-3057. PubMed ID: 29075753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Picture Description in the Assessment of Connected Speech Intelligibility in Parkinson's Disease: A Pilot Study.
    Johansson IL; Samuelsson C; Müller N
    Folia Phoniatr Logop; 2022; 74(5):320-334. PubMed ID: 35021169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.